New study tracks anemia drug MIRCERA in kidney patients
NCT ID NCT02567188
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 24 times
Summary
This study looked at how well the drug MIRCERA controls anemia in 144 adults with moderate chronic kidney disease (stages 3-4) who are not yet on dialysis. Researchers tracked hemoglobin levels and safety over 12 months in real-world clinics. The goal was to see if patients reach and maintain healthy hemoglobin targets without major side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Angeholm, S-262 81, Sweden
-
Study site
Bollnäs, 821 81, Sweden
-
Study site
Eskilstuna, 63188, Sweden
-
Study site
Gävle, 80187, Sweden
-
Study site
Gothenburg, 41345, Sweden
-
Study site
Gothenburg, S-402 76, Sweden
-
Study site
Huddinge, 14186, Sweden
-
Study site
Jönköping, 55185, Sweden
-
Study site
Karlshamn, S-374 80, Sweden
-
Study site
Karlstad, 65185, Sweden
-
Study site
Kristianstad, 29185, Sweden
-
Study site
Linköping, S-581 85, Sweden
-
Study site
Mölndal, S-431 80, Sweden
-
Study site
Norrköping, 60182, Sweden
-
Study site
Skövde, 54185, Sweden
-
Study site
Stockholm, 17176, Sweden
-
Study site
Stockholm, 18288, Sweden
-
Study site
Umeå, 90185, Sweden
-
Study site
Värnamo, 33185, Sweden
-
Study site
Västervik, 59381, Sweden
Conditions
Explore the condition pages connected to this study.